chr17-82830850-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_024702.3(ZNF750):āc.1464T>Gā(p.Pro488Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,613,060 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.012 ( 39 hom., cov: 32)
Exomes š: 0.0013 ( 33 hom. )
Consequence
ZNF750
NM_024702.3 synonymous
NM_024702.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.43
Genes affected
ZNF750 (HGNC:25843): (zinc finger protein 750) This gene encodes a protein with a nuclear localization site and a C2H2 zinc finger domain. Mutations in this gene have been associated with seborrhea-like dermatitis with psoriasiform elements. [provided by RefSeq, Jul 2008]
TBCD (HGNC:11581): (tubulin folding cofactor D) Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 17-82830850-A-C is Benign according to our data. Variant chr17-82830850-A-C is described in ClinVar as [Benign]. Clinvar id is 781338.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.43 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0119 (1809/152290) while in subpopulation AFR AF= 0.0411 (1709/41548). AF 95% confidence interval is 0.0395. There are 39 homozygotes in gnomad4. There are 825 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1809 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF750 | NM_024702.3 | c.1464T>G | p.Pro488Pro | synonymous_variant | 3/3 | ENST00000269394.4 | NP_078978.2 | |
TBCD | NM_005993.5 | c.1318+15916A>C | intron_variant | ENST00000355528.9 | NP_005984.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF750 | ENST00000269394.4 | c.1464T>G | p.Pro488Pro | synonymous_variant | 3/3 | 1 | NM_024702.3 | ENSP00000269394.3 | ||
TBCD | ENST00000355528.9 | c.1318+15916A>C | intron_variant | 1 | NM_005993.5 | ENSP00000347719.4 |
Frequencies
GnomAD3 genomes AF: 0.0119 AC: 1804AN: 152172Hom.: 39 Cov.: 32
GnomAD3 genomes
AF:
AC:
1804
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00298 AC: 736AN: 246818Hom.: 10 AF XY: 0.00229 AC XY: 308AN XY: 134514
GnomAD3 exomes
AF:
AC:
736
AN:
246818
Hom.:
AF XY:
AC XY:
308
AN XY:
134514
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00129 AC: 1888AN: 1460770Hom.: 33 Cov.: 36 AF XY: 0.00110 AC XY: 803AN XY: 726702
GnomAD4 exome
AF:
AC:
1888
AN:
1460770
Hom.:
Cov.:
36
AF XY:
AC XY:
803
AN XY:
726702
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0119 AC: 1809AN: 152290Hom.: 39 Cov.: 32 AF XY: 0.0111 AC XY: 825AN XY: 74478
GnomAD4 genome
AF:
AC:
1809
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
825
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at